These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 31209142)

  • 21. Mapping of the C3d receptor (CR2)-binding site and a neoantigenic site in the C3d domain of the third component of complement.
    Lambris JD; Ganu VS; Hirani S; Müller-Eberhard HJ
    Proc Natl Acad Sci U S A; 1985 Jun; 82(12):4235-9. PubMed ID: 2408276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced binding of immune complexes processed by erythrocyte CR1 (CD 35) receptors to purified CR2 (CD 21) receptors from tonsillar mononuclear cells.
    Rask R; Rasmussen JM; Jepsen HH; Svehag SE
    APMIS; 1989 Apr; 97(4):374-80. PubMed ID: 2524204
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polymer microbeads bound to C3 fragments for detecting and labeling cells with C3 receptors.
    Uchida T; Hosaka S; Murao Y
    Immunol Commun; 1982; 11(6):467-76. PubMed ID: 6220961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complement receptors type 1 (CR1, CD35) and 2 (CR2, CD21) cooperate in the binding of hydrolyzed complement factor 3 (C3i) to human B lymphocytes.
    Leslie RG; Prodinger WM; Nielsen CH
    Eur J Immunol; 2003 Dec; 33(12):3311-21. PubMed ID: 14635039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The evolution of mouse and human complement C3-binding proteins: divergence of form but conservation of function.
    Holers VM; Kinoshita T; Molina H
    Immunol Today; 1992 Jun; 13(6):231-6. PubMed ID: 1378280
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD21/CD35 in B cell activation.
    Carroll MC
    Semin Immunol; 1998 Aug; 10(4):279-86. PubMed ID: 9695184
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Induced activation of peripheral blood mononuclear cells and neutrophils in recipients of allogeneic kidneys].
    Semenkov VF; Serova LD; Filiptsev PIa; Sokol'skiĭ AS; Shabalin VN
    Biull Eksp Biol Med; 1995 May; 119(5):523-5. PubMed ID: 7579251
    [No Abstract]   [Full Text] [Related]  

  • 28. Third component of human complement: C3.
    Berger M
    Methods Enzymol; 1990; 184():619-28. PubMed ID: 2143801
    [No Abstract]   [Full Text] [Related]  

  • 29. Structure and function of the complement receptors, CR1 (CD35) and CR2 (CD21).
    Ahearn JM; Fearon DT
    Adv Immunol; 1989; 46():183-219. PubMed ID: 2551147
    [No Abstract]   [Full Text] [Related]  

  • 30. CR1 and the cell membrane proteins that bind C3 and C4. A basic and clinical review.
    Wilson JG; Andriopoulos NA; Fearon DT
    Immunol Res; 1987; 6(3):192-209. PubMed ID: 2960763
    [No Abstract]   [Full Text] [Related]  

  • 31. Binding reaction between the third human complement protein and small molecules.
    Law SK; Minich TM; Levine RP
    Biochemistry; 1981 Dec; 20(26):7457-63. PubMed ID: 7326238
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Localizations of regulatory proteins of complement components on RA synovial tissues--especially germinal centers.
    Sato T; Suda A; Yamakawa M; Watanabe Y; Kasazima T; Imai Y; Holzer G; Kotz R
    Adv Exp Med Biol; 1995; 378():313-5. PubMed ID: 8526082
    [No Abstract]   [Full Text] [Related]  

  • 33. Complement receptors CD21 and CD35 in humoral immunity.
    Roozendaal R; Carroll MC
    Immunol Rev; 2007 Oct; 219():157-66. PubMed ID: 17850488
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Defining the complement C3 binding site and the antigenic region of Haemonchus contortus GAPDH.
    Rajan P; Mishra PKK; Joshi P
    Parasite Immunol; 2019 Feb; 41(2):e12611. PubMed ID: 30548600
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cross-linking CD21/CD35 or CD19 increases both B7-1 and B7-2 expression on murine splenic B cells.
    Kozono Y; Abe R; Kozono H; Kelly RG; Azuma T; Holers VM
    J Immunol; 1998 Feb; 160(4):1565-72. PubMed ID: 9469411
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification and characterization of complement C3 receptors on human astrocytes.
    Gasque P; Chan P; Mauger C; Schouft MT; Singhrao S; Dierich MP; Morgan BP; Fontaine M
    J Immunol; 1996 Mar; 156(6):2247-55. PubMed ID: 8690915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hormonal regulation of complement components and receptors throughout the menstrual cycle.
    Hasty LA; Lambris JD; Lessey BA; Pruksananonda K; Lyttle CR
    Am J Obstet Gynecol; 1994 Jan; 170(1 Pt 1):168-75. PubMed ID: 7507644
    [TBL] [Abstract][Full Text] [Related]  

  • 38. IgG binding to cytoskeletal intermediate filaments activates the complement cascade.
    Hansson GK; Lagerstedt E; Bengtsson A; Heideman M
    Exp Cell Res; 1987 Jun; 170(2):338-50. PubMed ID: 3496230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role for complement receptors (CD21/CD35) in the regulation of recombination activating gene expression in murine peripheral B cells.
    Ohmori H; Magari M; Nakayama Y; Kanayama N; Hikida M
    Immunol Lett; 2002 Sep; 83(2):95-9. PubMed ID: 12067757
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A complement C3 fragment equivalent to mammalian C3d from the common carp (Cyprinus carpio): generation in serum after activation of the alternative pathway and detection of its receptor on the lymphocyte surface.
    Nakao M; Miura C; Itoh S; Nakahara M; Okumura K; Mutsuro J; Yano T
    Fish Shellfish Immunol; 2004 Feb; 16(2):139-49. PubMed ID: 15123318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.